Quest Diagnostics Incorporated (DGX)
NYSE: DGX · Real-Time Price · USD
182.91
-0.55 (-0.30%)
Sep 12, 2025, 4:00 PM EDT - Market closed
Quest Diagnostics Employees
Quest Diagnostics had 56,000 employees as of December 31, 2024. The number of employees increased by 8,000 or 16.67% compared to the previous year.
Employees
56,000
Change (1Y)
8,000
Growth (1Y)
16.67%
Revenue / Employee
$187,893
Profits / Employee
$16,875
Market Cap
20.45B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56,000 | 8,000 | 16.67% |
Dec 31, 2023 | 48,000 | -1,000 | -2.04% |
Dec 31, 2022 | 49,000 | 0 | - |
Dec 31, 2021 | 49,000 | 0 | - |
Dec 31, 2020 | 49,000 | 2,000 | 4.26% |
Dec 31, 2019 | 47,000 | 1,000 | 2.17% |
Dec 31, 2018 | 46,000 | 1,000 | 2.22% |
Dec 31, 2017 | 45,000 | 2,000 | 4.65% |
Dec 31, 2016 | 43,000 | -1,000 | -2.27% |
Dec 31, 2015 | 44,000 | -1,000 | -2.22% |
Dec 31, 2014 | 45,000 | 4,000 | 9.76% |
Dec 31, 2013 | 41,000 | 0 | - |
Dec 31, 2012 | 41,000 | -1,000 | -2.38% |
Dec 31, 2011 | 42,000 | 0 | - |
Dec 31, 2010 | 42,000 | -1,000 | -2.33% |
Dec 31, 2009 | 43,000 | 200 | 0.47% |
Dec 31, 2008 | 42,800 | -700 | -1.61% |
Dec 31, 2007 | 43,500 | 2,500 | 6.10% |
Dec 31, 2006 | 41,000 | -500 | -1.20% |
Dec 31, 2005 | 41,500 | 2,900 | 7.51% |
Dec 31, 2004 | 38,600 | 1,400 | 3.76% |
Dec 31, 2003 | 37,200 | 3,800 | 11.38% |
Dec 31, 2002 | 33,400 | 4,400 | 15.17% |
Dec 31, 2001 | 29,000 | 2,000 | 7.41% |
Dec 31, 2000 | 27,000 | 0 | - |
Dec 31, 1999 | 27,000 | 12,000 | 80.00% |
Dec 31, 1998 | 15,000 | -1,300 | -7.98% |
Dec 31, 1997 | 16,300 | -1,500 | -8.43% |
Dec 31, 1996 | 17,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
DGX News
- 2 days ago - Quest Diagnostics Incorporated (DGX) Presents At Baird Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 8 days ago - Quest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering - PRNewsWire
- 11 days ago - Fentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index - PRNewsWire
- 18 days ago - Corewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan - PRNewsWire
- 19 days ago - FDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics - PRNewsWire
- 4 weeks ago - Quest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference - PRNewsWire
- 4 weeks ago - Quest Diagnostics Declares Quarterly Cash Dividend - PRNewsWire
- 5 weeks ago - Mass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types - PRNewsWire